User Rating: / 0
PoorBest 

The chart below illustrates how our core equities performed relative to the S&P 500 Composite, comparative sectors within the S&P 500 and the composite of all equities managed by Osher Van de Voorde Investment Management for the year-to-date period through July.  We have assigned color codes for economic sectors and corresponding companies within those sectors to highlight how our core holdings fared on a relative basis.    

CompanyTickerSectorYTD % (+/-)
Berkshire HathawayBRK.BFinancials18.9%
Emerson ElectricEMRIndustrials16.3%
NYSE EuronextNYXFinancials14.5%
McDonald’sMCDDiscretionary11.7%
S&P Industrials Sector8.2%
PepsicoPEPStaples6.8%
S&P Discretionary Sector5.3%
Linear TechnologyLLTCTechnology4.3%
3M CompanyMMMIndustrials3.5%
United TechnologiesUTXIndustrials2.4%
S&P Financials Sector2.1%
VodafoneVODTelecom1.7%
NestleNSRGYStaples1.4%
S&P Staples Sector1.3%
Osher Van de Voorde Equity Composite-1.00%
S&P 500 Index-1.21%
Automatic DataADPTechnology-3.6%
OracleORCLTechnology-3.6%
Cisco SystemsCSCOTechnology-3.6%
Colgate PalmoliveCLStaples-3.9%
S&P Telecommunications Sector-3.9%
Wal-MartWMTStaples-4.2%
S&P Technology Sector-4.6%
S&P Energy Sector-6.2%
S&P Health Care Sector-8.6%
Abbott LabsABTHealth Care-9.1%
Johnson & JohnsonJNJHealth Care-9.8%
NovartisNVSHealth Care-10.5%
Exxon MobilXOMEnergy-12.5%
Teva PharmaceuticalsTEVAHealth Care-13%
L-3 CommunicationsLLLIndustrials-16%
QualcommQCOMTechnology-17.7%

It is interesting to us that we managed to top the overall market despite remaining  underweighted in two of this year’s top performing sectors, Financials and Discretionary.  Clearly, our picks within these underweighted sectors (BRK.B, NYX and MCD) boosted our performance.  Our decision to overweight both Industrials and Staples while underweighting Energy contributed to portfolio performance, while our overweight investment in Health Care proved to be a drag.  Four of our five picks within Technology topped the performance of the overall sector.  While not shown on the chart, our non-core investments in Emerging Markets made positive contributions to performance.  As you might expect, to better position portfolios for the rest of 2010 and beyond, we have added to most of the holdings that underperformed during the first part of the year, especially Qualcomm, Exxon Mobil and Teva Pharmaceuticals.